The low average scores in patients with p.R75P mutations may be due to a lower frequency of temporal pole lesions and older age onset compared with other CADASIL subtypes, such as cysteine-altering NOTCH3 mutations (Ueda et al., 2015). The gene discussed is NOTCH3; the disease is CADASIL.